Gary Pace

Insider Reports History

Entity
Individual
Location
C/O Resmed Inc, 14040 Danielson Street, Poway, California
Signature
/s/ Gary Pace
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary Pace:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cardiff Oncology, Inc. Director Common Stock 698K $956K $1.37 Dec 19, 2023 Direct
Pacira BioSciences, Inc. Director Common Stock 22.1K $677K $30.60 Mar 8, 2024 Direct
Cardiff Oncology, Inc. Director Stock Options 147K $382K $2.60 Jun 27, 2024 Direct
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 12.9K Jun 14, 2023 Direct

Insider Reports Filed by Gary Pace

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRDF Cardiff Oncology, Inc. Jun 27, 2024 1 $0 4 Jul 1, 2024 Director
PCRX Pacira BioSciences, Inc. Mar 6, 2024 3 -$3.66M 4 Mar 8, 2024 Director
CRDF Cardiff Oncology, Inc. Dec 19, 2023 1 $41.1K 4 Dec 19, 2023 Director
CRDF Cardiff Oncology, Inc. Nov 10, 2023 1 $22.5K 4 Nov 14, 2023 Director
CRDF Cardiff Oncology, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
PCRX Pacira BioSciences, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
PCRX Pacira BioSciences, Inc. May 11, 2023 3 -$227 4 May 15, 2023 Director
CRDF Cardiff Oncology, Inc. Sep 15, 2022 1 $257K 4 Sep 19, 2022 Director
PCRX Pacira BioSciences, Inc. Jun 8, 2022 2 $0 4 Jun 8, 2022 Director
CRDF Cardiff Oncology, Inc. Mar 9, 2022 1 $0 4 Mar 11, 2022 Director
PCRX Pacira BioSciences, Inc. Mar 3, 2022 2 $75.7K 4 Mar 7, 2022 Director
PCRX Pacira BioSciences, Inc. Feb 28, 2022 10 -$1.68M 4 Mar 1, 2022 Director
CRDF Cardiff Oncology, Inc. Sep 21, 2021 1 $203K 4 Sep 22, 2021 Director
CRDF Cardiff Oncology, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
PCRX Pacira BioSciences, Inc. May 13, 2021 3 $0 4 Jun 11, 2021 Director